Price Alert

PROCEPT BioRobotics Corpo... (PRCT)

NASDAQ: PRCT · Real-Time Price · USD

41.69

1.57 (3.91%)

At close: Aug 15, 2025, 2:57 PM

PROCEPT BioRobotics Statistics

Share Statistics

PROCEPT BioRobotics has 55.33M shares outstanding. The number of shares has increased by 6.54% in one year.

Shares Outstanding	55.33M
Shares Change (YoY)	6.54%
Shares Change (QoQ)	0.93%
Owned by Institutions (%)	91.85%
Shares Floating	52.9M
Failed to Deliver (FTD) Shares	115
FTD / Avg. Volume	0.01%

Short Selling Information

The latest short interest is 6.82M, so 12.45% of the outstanding shares have been sold short.

Short Interest	6.82M
Short % of Shares Out	12.45%
Short % of Float	16.76%
Short Ratio (days to cover)	9.62

Valuation Ratios

The PE ratio is -45.91 and the forward PE ratio is -38.13. PROCEPT BioRobotics's PEG ratio is 2.1.

PE Ratio	-45.91
Forward PE	-38.13
PS Ratio	18.7
Forward PS	5
PB Ratio	10.43
P/FCF Ratio	-40.5
PEG Ratio	2.1

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for PROCEPT BioRobotics.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.07, with a Debt / Equity ratio of 0.2.

Current Ratio	9.07
Quick Ratio	8.01
Debt / Equity	0.2
Debt / EBITDA	-0.98
Debt / FCF	-0.77
Interest Coverage	-23.09

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$296.96K
Profits Per Employee	$-120.92K
Employee Count	756
Asset Turnover	0.42
Inventory Turnover	1.56

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by -38.77% in the last 52 weeks. The beta is 1.04, so PROCEPT BioRobotics's price volatility has been higher than the market average.

Beta	1.04
52-Week Price Change	-38.77%
50-Day Moving Average	56.85
200-Day Moving Average	67.88
Relative Strength Index (RSI)	19.28
Average Volume (20 Days)	1,049,817

Income Statement

In the last 12 months, PROCEPT BioRobotics had revenue of 224.5M and earned -91.41M in profits. Earnings per share was -1.75.

Revenue	224.5M
Gross Profit	137.1M
Operating Income	-96.61M
Net Income	-91.41M
EBITDA	-82M
EBIT	-87.23M
Earnings Per Share (EPS)	-1.75

Full Income Statement

Balance Sheet

The company has 333.73M in cash and 80.25M in debt, giving a net cash position of 253.47M.

Cash & Cash Equivalents	333.73M
Total Debt	80.25M
Net Cash	253.47M
Retained Earnings	-545.99M
Total Assets	519.38M
Working Capital	413.73M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -99.21M and capital expenditures -4.41M, giving a free cash flow of -103.62M.

Operating Cash Flow	-99.21M
Capital Expenditures	-4.41M
Free Cash Flow	-103.62M
FCF Per Share	-1.99

Full Cash Flow Statement

Margins

Gross margin is 61.07%, with operating and profit margins of -43.04% and -40.72%.

Gross Margin	61.07%
Operating Margin	-43.04%
Pretax Margin	-40.72%
Profit Margin	-40.72%
EBITDA Margin	-36.52%
EBIT Margin	-43.04%
FCF Margin	-46.16%

Dividends & Yields

PRCT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for PRCT is $70, which is 80.5% higher than the current price. The consensus rating is "Buy".

Price Target	$70
Price Target Difference	80.5%
Analyst Consensus	Buy
Analyst Count	8

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	13.55
Piotroski F-Score	4